In our study, ESR, ALB, AST, CRP, PLT, and lymphocyte percentage were identified as important variables and utilized to construct a nomogram for predicting small bowel MH in pediatric CD, which may monitor response to the therapy and provide early warnings of relapse. This evidence concerns the gene ALB and Cowden disease.